R. Michael Blaese: still blazing a path of his own.
- Resource Type
- journal article
- Authors
- Jenks, Susan; Jenks, S
- Source
- JNCI: Journal of the National Cancer Institute. 08/19/98, Vol. 90 Issue 16, p1188-1191. 4p.
- Subject
- *IMMUNOLOGICAL deficiency syndrome treatment
*TUMOR treatment
*GENE therapy
*HYDROLASES
*IMMUNOLOGICAL deficiency syndromes
*NUCLEOTIDES
*TUMORS
*THERAPEUTICS
- Language
- ISSN
- 0027-8874
Profiles chief scientific officer and president of the Molecular Pharmaceuticals Division of a Pennsylvania-based biotech company, R. Michael Blaese. Information on Blaese's profession; Identification of the genetic disease that Blaese believes could be fixed by traditional gene therapy; Comments from Blaese. INSET: Gene therapy infants faring well.